SCHEMBL27470293

SCHEMBL27470293

O=C(O)c1ccc(-c2ccccc2OC(F)(F)F)nc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LDHA P00338 1/20 0.53
▸ RXRA P19793 1/20 0.52
▸ RXRB P28702 1/20 0.52
▸ RXRG P48443 1/20 0.52
▸ P4HA1 P13674 2/20 0.51
▸ P4HTM Q9NXG6 1/20 0.51
▸ CSNK2A2 P19784 1/20 0.49
▸ CSNK2B P67870 1/20 0.49
▸ RORC P51449 2/20 0.48
▸ FFAR4 Q5NUL3 1/20 0.47
▸ ABL1 P00519 1/20 0.46
▸ NR1H4 Q96RI1 2/20 0.45
▸ SCN10A Q9Y5Y9 1/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ AURKA O14965 1/20 0.43
▸ HSD17B13 Q7Z5P4 1/20 0.43
▸ SCN9A Q15858 1/20 0.43
▸ HDAC3 O15379 1/20 0.43
▸ HDAC1 Q13547 1/20 0.43
▸ HDAC2 Q92769 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22445719 0.81 LDHA (0.57) LDHARXRAP4HA1P4HTMHDAC1
SCHEMBL8521764 0.80 P4HTM (0.73) LDHAP4HA1P4HTMALDH1A1
SCHEMBL13876205 0.80 EPHX2 (0.66) RORCHSD17B13HDAC3HDAC1HDAC2
SCHEMBL21310804 0.80 KDM4C (0.56) RXRARXRBRXRGP4HA1CSNK2A2
SCHEMBL8303037 0.78 LDHA (0.57) LDHARXRARXRBRXRGP4HA1
SCHEMBL536004 0.78 FFAR4 (0.59) RXRARXRBRXRGCSNK2A2CSNK2B
SCHEMBL16195648 0.77 SCN9A (0.48) CSNK2A2CSNK2BFFAR4ABL1SCN9A
SCHEMBL14089991 0.77 RXRA (0.54) RXRARXRBRXRGCSNK2A2CSNK2B
SCHEMBL14744175 0.77 ALOX5AP (0.51) RORCFFAR4ABL1SCN10ASCN9A
SCHEMBL4901543 0.76 RXRA (0.51) RXRARXRBRXRGCSNK2A2CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4618978-A1 COMPOUNDS, COMPOSITIONS, AND METHODS Tenvie Therapeutics Inc. (US) 2025-09-24 — — EP disclosed
WO-2024108147-A1 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2024-05-23 — — WO disclosed
WO-2024108147-A1 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2024-05-23 — — WO disclosed
Send feedback